Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Marjot

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
NMR in Biomedicine|November 22, 2018
Mapping tissue water T<sub>1</sub> in the liver using the MOLLI T<sub>1</sub> method in the presence of fat, iron and B<sub>0</sub> inhomogeneityFerenc E Mozes, Elizabeth M Tunnicliffe, Ahmad Moolla, et al.
Nature Reviews. Gastroenterology & Hepatology|March 11, 2021
COVID-19 and liver disease: mechanistic and clinical perspectivesThomas Marjot, Gwilym J Webb, Alfred S Barritt, et al.
The Lancet. Gastroenterology & Hepatology|January 14, 2021
SARS-CoV-2 vaccination in patients with liver disease: responding to the next big questionThomas Marjot, Gwilym J Webb, Alfred S Barritt, et al.
Endocrinology|June 7, 2017
RAMP2 Influences Glucagon Receptor Pharmacology via Trafficking and SignalingJaimini Cegla, Ben J Jones, James V Gardiner, et al.
JHEP Reports : Innovation in Hepatology|August 25, 2020
Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemicTobias Boettler, Thomas Marjot, Philip N Newsome, et al.
Frontline Gastroenterology|November 5, 2019
A multidisciplinary approach to the management of NAFLD is associated with improvement in markers of liver and cardio-metabolic healthAhmad Moolla, Kenzo Motohashi, Thomas Marjot, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|June 10, 2020
Sodium-glucose cotransporter 2 inhibition does not reduce hepatic steatosis in overweight, insulin-resistant patients without type 2 diabetesThomas Marjot, Charlotte J Green, Catriona A Charlton, et al.
Journal of Hepatology|July 22, 2022
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paperThomas Marjot, Christiane S Eberhardt, Tobias Boettler, et al.
Journal of Pediatric Gastroenterology and Nutrition|October 16, 2021
SARS-CoV-2 in Pediatric Liver Transplant Recipients: The European ExperienceGustav Buescher, Marcial Sebode, Thomas Marjot, et al.
European Journal of Endocrinology|January 17, 2022
Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesisCharlotte J Green, Thomas Marjot, John Walsby-Tickle, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
NMR in Biomedicine|November 22, 2018
Mapping tissue water T<sub>1</sub> in the liver using the MOLLI T<sub>1</sub> method in the presence of fat, iron and B<sub>0</sub> inhomogeneityFerenc E Mozes, Elizabeth M Tunnicliffe, Ahmad Moolla, et al.
Nature Reviews. Gastroenterology & Hepatology|March 11, 2021
COVID-19 and liver disease: mechanistic and clinical perspectivesThomas Marjot, Gwilym J Webb, Alfred S Barritt, et al.
The Lancet. Gastroenterology & Hepatology|January 14, 2021
SARS-CoV-2 vaccination in patients with liver disease: responding to the next big questionThomas Marjot, Gwilym J Webb, Alfred S Barritt, et al.
Endocrinology|June 7, 2017
RAMP2 Influences Glucagon Receptor Pharmacology via Trafficking and SignalingJaimini Cegla, Ben J Jones, James V Gardiner, et al.
JHEP Reports : Innovation in Hepatology|August 25, 2020
Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemicTobias Boettler, Thomas Marjot, Philip N Newsome, et al.
Frontline Gastroenterology|November 5, 2019
A multidisciplinary approach to the management of NAFLD is associated with improvement in markers of liver and cardio-metabolic healthAhmad Moolla, Kenzo Motohashi, Thomas Marjot, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|June 10, 2020
Sodium-glucose cotransporter 2 inhibition does not reduce hepatic steatosis in overweight, insulin-resistant patients without type 2 diabetesThomas Marjot, Charlotte J Green, Catriona A Charlton, et al.
Journal of Hepatology|July 22, 2022
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paperThomas Marjot, Christiane S Eberhardt, Tobias Boettler, et al.
Journal of Pediatric Gastroenterology and Nutrition|October 16, 2021
SARS-CoV-2 in Pediatric Liver Transplant Recipients: The European ExperienceGustav Buescher, Marcial Sebode, Thomas Marjot, et al.
European Journal of Endocrinology|January 17, 2022
Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesisCharlotte J Green, Thomas Marjot, John Walsby-Tickle, et al.
Pageof 7